Analysts remain optimistic that Cambrex Corporation (NYSE:CBM) will enjoy revenue and earnings growth next year despite sales pressure on its leading product; Anthony Bozza of Lakewood Capital believes the company’s earnings could actually decline by as much as 30% in 2018.
That’s the message delivered by Bozza in the fund’s latest investor letter, which was released this week. We have already covered other parts of Lakewood Capital’s Q3 Investor Letter, discussing the fund’s new long...
